journal article·2023-10Open access

A Selective, Hydrogel‐Based Prodrug Delivery System Efficiently Activates a Suicide Gene to Remove Undifferentiated Human Stem Cells Within Neural Grafts

Kevin C. L. Law, Negar Mahmoudi, Zahra E. Zadeh, Richard. J. Williams, Cameron P. J. Hunt, Andras Nagy, Lachlan H. Thompson, David R. Nisbet, Clare L. Parish

Advanced Functional Materials· Volume 33· Issue 43

Abstract

Abstract The directed differentiation of human pluripotent stem cells (hPSCs) into defined populations has advanced regenerative medicine, especially for Parkinson's disease where clinical trials are underway. Despite this, tumorigenic risks associated with incompletely patterned and/or quiescent proliferative cells within grafts remain. Addressing this, donor stem cells carrying the suicide gene, thymidine kinase (activated by the prodrug ganciclovir, GCV), are employed to enable the programmed ablation of proliferative cells within neural grafts. However, coinciding the short half‐life of GCV with the short S‐phase of neural progenitors is a key challenge. To overcome this, a smart hydrogel delivery matrix is fabricatedto prolong GCV presentation. Following matrix embedment, GCV retains its functionality, demonstrated by ablation of hPSCs and proliferating neural progenitors in vitro. A prolonged GCV release is measured by mass spectrometry following the injection of a GCV‐functionalized hydrogel into mouse brains. Compared to suboptimal, daily systemic GCV injections, the intracerebral delivery of the functionalized hydrogel, as a “one‐off treatment”, reduce proliferative cells in both hPSC‐derived teratomas and neural grafts, without affecting the graft's functional unit (i.e., neurons). It is demonstrated that a functionalized biomaterial can enhance prodrug delivery and address safety concerns associated with the use of hPSCs for brain repair.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Pluripotent Stem Cells Research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Florey Institute of Neuroscience and Mental Health The University of Melbourne Parkville VIC 3052 Australia

Laboratory of Advanced Biomaterials Research School of Chemistry and the John Curtin School of Medical Research Australian National University Canberra ACT 2601 Australia

ANU College of Engineering & Computer Science Canberra ACT 2601 Australia

The Graeme Clark Institute The University of Melbourne Parkville VIC 3010 Australia

Department of Biomedical Engineering Faculty of Engineering and Information Technology The University of Melbourne Parkville VIC 3010 Australia

Institute for Mental and Physical Health and Clinical Translation School of Medicine Deakin University Warun Ponds VIC 3216 Australia

Lunenfeld‐Tanenbaum Research Institute Mount Sinai Hospital M5G 1X5 Toronto Canada

Charles Perkins Centre The University of Sydney Camperdown NSW 2006 Australia

Melbourne Medical School Faculty of Medicine, Dentistry and Health Science The University of Melbourne Parkville VIC 3010 Australia

Department of Anatomy & Physiology The University of Melbourne Melbourne VIC 3010 Australia

References (58)

Show source-provided references
1. 10.3233/JPD-16079810.3233/JPD-160798 ↗
2. 10.5966/sctm.2014-001110.5966/sctm.2014-0011 ↗
3. 10.1523/JNEUROSCI.1160-19.201910.1523/JNEUROSCI.1160-19.2019 ↗
4. 10.1016/j.stemcr.2014.01.01310.1016/j.stemcr.2014.01.013 ↗
5. 10.1074/mcp.RA118.00080910.1074/mcp.RA118.000809 ↗
6. 10.1016/j.stemcr.2017.08.01610.1016/j.stemcr.2017.08.016 ↗
7. 10.1038/ncomms1309710.1038/ncomms13097 ↗
8. 10.1038/s41467-021-23125-910.1038/s41467-021-23125-9 ↗
9. 10.1038/s41586-018-0733-710.1038/s41586-018-0733-7 ↗
10. 10.3389/fncel.2021.63802110.3389/fncel.2021.638021 ↗
11. 10.1016/j.antiviral.2016.05.01910.1016/j.antiviral.2016.05.019 ↗
12. 10.1124/dmd.114.05984010.1124/dmd.114.059840 ↗
13. 10.1038/ncomms115510.1038/ncomms1155 ↗
14. 10.1038/natrevmats.2016.7110.1038/natrevmats.2016.71 ↗
15. Tseng A. · Can. J. Infect. Dis. · 1996 · 7 · 183
16. 10.1080/10717544.2017.141344810.1080/10717544.2017.1413448 ↗
17. 10.2174/187504350100301001010.2174/1875043501003010010 ↗
18. 10.3390/gels903019910.3390/gels9030199 ↗
19. 10.1039/C4TB01391C10.1039/C4TB01391C ↗
20. 10.1002/term.258210.1002/term.2582 ↗
21. 10.1016/j.celrep.2017.07.06910.1016/j.celrep.2017.07.069 ↗
22. 10.1002/adfm.20217034410.1002/adfm.202170344 ↗
23. 10.1002/adbi.20180011310.1002/adbi.201800113 ↗
24. 10.3390/ijms2309464610.3390/ijms23094646 ↗
25. 10.1038/s41467-023-36133-810.1038/s41467-023-36133-8 ↗
26. 10.1039/c3sm27758e10.1039/c3sm27758e ↗
27. 10.3390/polym301060210.3390/polym3010602 ↗
28. 10.5966/sctm.2016-007310.5966/sctm.2016-0073 ↗
29. 10.1016/j.xpro.2020.10006510.1016/j.xpro.2020.100065 ↗
30. 10.1016/j.stem.2020.01.01010.1016/j.stem.2020.01.010 ↗
31. 10.1016/j.stem.2022.01.01310.1016/j.stem.2022.01.013 ↗
32. 10.1039/C1CC15551B10.1039/C1CC15551B ↗
33. 10.1016/j.actbio.2016.04.03810.1016/j.actbio.2016.04.038 ↗
34. 10.1002/bip.2246910.1002/bip.22469 ↗
35. 10.1016/j.nano.2016.01.00910.1016/j.nano.2016.01.009 ↗
36. 10.1242/jcs.07100110.1242/jcs.071001 ↗
37. 10.1016/j.celrep.2012.04.00910.1016/j.celrep.2012.04.009 ↗
38. 10.1016/j.addr.2016.06.01310.1016/j.addr.2016.06.013 ↗
39. 10.1038/s41467-022-28787-710.1038/s41467-022-28787-7 ↗
40. 10.1016/j.biomaterials.2015.09.03910.1016/j.biomaterials.2015.09.039 ↗
41. 10.1080/10717544.2021.200993710.1080/10717544.2021.2009937 ↗
42. Tieng V. · Mol. Ther. · 2016 · 6
43. 10.1080/00365520075002323710.1080/003655200750023237 ↗
44. 10.1002/cne.2205210.1002/cne.22052 ↗
45. 10.1128/AAC.36.9.183710.1128/AAC.36.9.1837 ↗
46. 10.1038/mt.2012.16610.1038/mt.2012.166 ↗
47. 10.1016/j.omtm.2022.07.00110.1016/j.omtm.2022.07.001 ↗
48. 10.3390/cells1103050210.3390/cells11030502 ↗
49. 10.1111/j.1600-6143.2004.00382.x10.1111/j.1600-6143.2004.00382.x ↗
50. 10.1038/sj.gt.330078410.1038/sj.gt.3300784 ↗
51. 10.1038/s41591-019-0507-210.1038/s41591-019-0507-2 ↗
52. 10.1038/s41583-019-0257-710.1038/s41583-019-0257-7 ↗
53. 10.3389/fphar.2015.0009510.3389/fphar.2015.00095 ↗
54. 10.1001/archopht.1992.0108014011103710.1001/archopht.1992.01080140111037 ↗
55. 10.1056/NEJM19970710337020310.1056/NEJM199707103370203 ↗
56. 10.1080/10717544.2021.189224210.1080/10717544.2021.1892242 ↗
57. 10.1016/S0079-6123(06)61027-310.1016/S0079-6123(06)61027-3 ↗
58. 10.1089/scd.2009.045210.1089/scd.2009.0452 ↗